Reporting and interpretation of results from clinical trials that did not claim a treatment difference: survey of four general medical journals

被引:25
作者
Gates, Simon [1 ]
Ealing, Elizabeth [2 ]
机构
[1] Univ Birmingham, Canc Res UK Clin Trials Unit, Birmingham, W Midlands, England
[2] Univ Warwick, Warwick Clin Trials Unit, Coventry, W Midlands, England
来源
BMJ OPEN | 2019年 / 9卷 / 09期
关键词
clinical trials; reporting; statistics & research methods; CONFIDENCE-INTERVALS; P-VALUES; MISINTERPRETATION; STATISTICS;
D O I
10.1136/bmjopen-2018-024785
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To describe and summarise how the results of randomised controlled trials (RCTs) that did not find a significant treatment effect are reported, and to estimate how commonly trial reports make unwarranted claims. Design We performed a retrospective survey of published RCTs, published in four high impact factor general medical journals between June 2016 and June 2017. Setting Trials conducted in all settings were included. Participants 94 reports of RCTs that did not find a difference in their main comparison or comparisons were included. Interventions All interventions. Primary and secondary outcomes We recorded the way the results of each trial for its primary outcome or outcomes were described in Results and Conclusions sections of the Abstract, using a 10-category classification. Other outcomes were whether confidence intervals (CIs) and p values were presented for the main treatment comparisons, and whether the results and conclusions referred to measures of uncertainty. We estimated the proportion of papers that made claims that were not justified by the results, or were open to multiple interpretations. Results 94 trial reports (120 treatment comparisons) were included. In Results sections, for 58/120 comparisons (48.3%) the results of the study were re-stated, without interpretation, and 38/120 (31.7%) stated that there was no statistically significant difference. In Conclusions, 65/120 treatment comparisons (54.2%) stated that there was no treatment benefit, 14/120 (11.7%) that there was no significant benefit and 16/120 (13.3%) that there was no significant difference. CIs and p values were both presented by 84% of studies (79/94), but only 3/94 studies referred to uncertainty when drawing conclusions. Conclusions The majority of trials (54.2%) inappropriately interpreted a result that was not statistically significant as indicating no treatment benefit. Very few studies interpreted the result as indicating a lack of evidence against the null hypothesis of zero difference between the trial arms.
引用
收藏
页数:7
相关论文
共 27 条
  • [1] Survey of claims of no effect in abstracts of Cochrane reviews
    Alderson, P
    Chalmers, I
    [J]. BRITISH MEDICAL JOURNAL, 2003, 326 (7387): : 475 - 475
  • [2] STATISTICS NOTES - ABSENCE OF EVIDENCE IS NOT EVIDENCE OF ABSENCE
    ALTMAN, DG
    BLAND, JM
    [J]. BRITISH MEDICAL JOURNAL, 1995, 311 (7003) : 485 - 485
  • [3] Retire statistical significance
    Amrhein, Valentin
    Greenland, Sander
    McShane, Blake
    [J]. NATURE, 2019, 567 (7748) : 305 - 307
  • [4] [Anonymous], 2002, Methods Psychol Res, DOI DOI 10.1119/1.2343497
  • [5] Redefine statistical significance
    Benjamin, Daniel J.
    Berger, James O.
    Johannesson, Magnus
    Nosek, Brian A.
    Wagenmakers, E. -J.
    Berk, Richard
    Bollen, Kenneth A.
    Brembs, Bjoern
    Brown, Lawrence
    Camerer, Colin
    Cesarini, David
    Chambers, Christopher D.
    Clyde, Merlise
    Cook, Thomas D.
    De Boeck, Paul
    Dienes, Zoltan
    Dreber, Anna
    Easwaran, Kenny
    Efferson, Charles
    Fehr, Ernst
    Fidler, Fiona
    Field, Andy P.
    Forster, Malcolm
    George, Edward I.
    Gonzalez, Richard
    Goodman, Steven
    Green, Edwin
    Green, Donald P.
    Greenwald, Anthony
    Hadfield, Jarrod D.
    Hedges, Larry V.
    Held, Leonhard
    Ho, Teck Hua
    Hoijtink, Herbert
    Hruschka, Daniel J.
    Imai, Kosuke
    Imbens, Guido
    Ioannidis, John P. A.
    Jeon, Minjeong
    Jones, James Holland
    Kirchler, Michael
    Laibson, David
    List, John
    Little, Roderick
    Lupia, Arthur
    Machery, Edouard
    Maxwell, Scott E.
    McCarthy, Michael
    Moore, Don
    Morgan, Stephen L.
    [J]. NATURE HUMAN BEHAVIOUR, 2018, 2 (01): : 6 - 10
  • [6] Datamethods, 2018, LANG COMM FREQ RES T
  • [7] Editors can lead researchers to confidence intervals, but can't make them think - Statistical reform lessons from medicine
    Fidler, F
    Thomason, N
    Cumming, G
    Finch, S
    Leeman, J
    [J]. PSYCHOLOGICAL SCIENCE, 2004, 15 (02) : 119 - 126
  • [8] CONFIDENCE-INTERVALS RATHER THAN P-VALUES - ESTIMATION RATHER THAN HYPOTHESIS-TESTING
    GARDNER, MJ
    ALTMAN, DG
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1986, 292 (6522): : 746 - 750
  • [9] The difference between "significant" and "not significant" is not itself statistically significant
    Gelman, Andrew
    Stern, Hal
    [J]. AMERICAN STATISTICIAN, 2006, 60 (04) : 328 - 331
  • [10] Interpretation of CIs in clinical trials with non-significant results: systematic review and recommendations
    Gewandter, Jennifer S.
    McDermott, Michael P.
    Kitt, Rachel A.
    Chaudari, Jenna
    Koch, James G.
    Evans, Scott R.
    Gross, Robert A.
    Markman, John D.
    Turk, Dennis C.
    Dworkin, Robert H.
    [J]. BMJ OPEN, 2017, 7 (07):